GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Aosaikang Pharmaceutical Co Ltd (SZSE:002755) » Definitions » Deferred Policy Acquisition Costs

Beijing Aosaikang Pharmaceutical Co (SZSE:002755) Deferred Policy Acquisition Costs


View and export this data going back to 2015. Start your Free Trial

What is Beijing Aosaikang Pharmaceutical Co Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Beijing Aosaikang Pharmaceutical Co (SZSE:002755) Business Description

Traded in Other Exchanges
N/A
Address
South Fourth Ring Road, Building 28 , 7th District, No. 188, Fengtai District, Beijing, CHN, 100070
Beijing Aosaikang Pharmaceutical Co Ltd is engaged in the research and development of domestic high-end first imitation drugs, chemical drugs, and biological drugs. Its products focus on digestion, tumors, drug-resistant infections, and chronic diseases.
Executives
Wang Zheng Yong Executives
Li Xiao Xin Supervisors
Ren Wei Rong Directors, executives
Chen Qing Cai Directors, Directors, and Executives
Du Chao Yang Executives
Ma Yao Chuan Director
Wu Zhan Feng Supervisors
Guo Hong Jie Director